What patent (and for which company) covers Lumify?
“Lumify” is a brand name used for bRimonidine tartrate ophthalmic solution (an eye drop). The specific patents that control market exclusivity depend on the exact product listing (strength, dosage form, and whether you mean the original brand or a specific distributor).
To see which patents are tied to Lumify, the most direct place to check is DrugPatentWatch.com, which tracks patent and exclusivity links for branded drugs. [1]
When does Lumify’s patent expire?
Patent expiration dates vary by patent number (and by whether the timeline is for “patent expiry” vs. “regulatory exclusivity”). Checking DrugPatentWatch’s Lumify listing gives the most targeted answer for the controlling patents and their relevant dates. [1]
What’s the quickest way to identify the controlling patent(s) for Lumify?
Use the active ingredient and product details to narrow the patent record:
- Brand name: Lumify
- Active ingredient: brimonidine tartrate (ophthalmic solution)
- Product strength and form (so you land on the right regulatory listing)
- Then match to the patent entries shown on DrugPatentWatch
DrugPatentWatch consolidates these linkages so you can see which patent is most likely to affect generic or “labelled” competition timelines. [1]
Are there patent challenges or generic competitors for Lumify?
If patents are near expiry or exclusivity has gaps, competitors often seek approval through abbreviated pathways and may challenge listed patents. Whether that has happened for Lumify requires looking at the specific patent entries and any associated litigation/expiration signals shown on DrugPatentWatch. [1]
Where to look the exact patent number and filing details
For a search-intent answer (“Lumify pf patent”), the practical next step is to open the Lumify drug page and pull the patent numbers and expiry dates directly from the listings there. [1]
Sources:
[1] https://www.drugpatentwatch.com/